These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19711335)

  • 1. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.
    Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.
    Zisook S; Kasckow JW; Golshan S; Fellows I; Solorzano E; Lehman D; Mohamed S; Jeste DV
    J Clin Psychiatry; 2009 Apr; 70(4):562-71. PubMed ID: 19192468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
    Rocca P; Calvarese P; Faggiano F; Marchiaro L; Mathis F; Rivoira E; Taricco B; Bogetto F
    J Clin Psychiatry; 2005 Mar; 66(3):360-9. PubMed ID: 15766303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia.
    Zisook S; Montross L; Kasckow J; Mohamed S; Palmer BW; Patterson TL; Golshan S; Fellows I; Lehman D; Solorzano E
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1005-14. PubMed ID: 18056819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression?
    Dawes SE; Palmer BW; Meeks T; Golshan S; Kasckow J; Mohamed S; Zisook S
    Neuropsychobiology; 2012; 65(3):168-72. PubMed ID: 22456094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response.
    Kasckow J; Fellows I; Golshan S; Solorzano E; Meeks T; Zisook S
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):853-7. PubMed ID: 20808103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life.
    Kasckow J; Montross L; Golshan S; Mohamed S; Patterson T; Sollanzano E; Zisook S
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1223-8. PubMed ID: 17506025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.
    Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S
    J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment.
    Blank S; Lenze EJ; Mulsant BH; Dew MA; Karp JF; Shear MK; Houck PR; Miller MD; Pollock BG; Tracey B; Reynolds CF
    J Clin Psychiatry; 2006 Mar; 67(3):468-72. PubMed ID: 16649835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effects of antidepressants on negative symptoms in schizophrenia.
    Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
    J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression.
    Bent-Hansen J; Lunde M; Klysner R; Andersen M; Tanghøj P; Solstad K; Bech P
    Pharmacopsychiatry; 2003 Nov; 36(6):313-6. PubMed ID: 14663657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label trial of citalopram for major depression in patients with hepatitis C.
    Gleason OC; Yates WR; Isbell MD; Philipsen MA
    J Clin Psychiatry; 2002 Mar; 63(3):194-8. PubMed ID: 11926717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents.
    Wagner KD; Robb AS; Findling RL; Jin J; Gutierrez MM; Heydorn WE
    Am J Psychiatry; 2004 Jun; 161(6):1079-83. PubMed ID: 15169696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurring depressive symptoms in the older patient with schizophrenia.
    Kasckow JW; Zisook S
    Drugs Aging; 2008; 25(8):631-47. PubMed ID: 18665657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.